Artemisia annua is celebrated for its production of artemisinin, a powerful antimalarial agent. Although its glandular secretory trichomes have been the focus of extensive research, a complete understanding of their metabolic processes remains elusive. Previous studies have primarily centered on artemisinin, often overlooking other crucial metabolic pathways. Addressing these knowledge gaps is crucial for unlocking new therapeutic potentials within this medicinal plant.
Led by Shanghai Jiao Tong University researchers and published (DOI: 10.1093/hr/uhae174) on June 24, 2024, in Horticulture Research, the study explores the metabolic disturbances of a mutant strain of Artemisia annua, designated as TRICHOME DEVELOPMENTAL DEFECTS 1 (tdd1). This mutant displayed impaired glandular secretory trichome (GST) functionality, severely compromising artemisinin production. Utilizing integrated multi-omics profiling, the researchers identified complex metabolic disruptions, offering fresh perspectives on plant secondary metabolism.
The study analyzed the tdd1 mutant, which displayed pronounced defects in GSTs, crucial for artemisinin biosynthesis. In both young and mature leaves, artemisinin and its precursors were nearly undetectable, highlighting a significant disruption in the metabolic pathway. Through advanced Liquid Chromatography-Mass Spectrometry (LC–MS) and Gas Chromatography-Mass Spectrometry (GC–MS) analyses, 836 metabolites were identified, including flavonoids and terpenoids, many of which were absent in the mutant. The research revealed key differences in the Mevalonate Pathway (MVA) and (Methylerythritol Phosphate Pathway) MEP pathways, with minimal expression of GST-specific genes linked to artemisinin biosynthesis. These findings underline the broader metabolic impact of GST defects and underscore their importance in secondary metabolite synthesis. The study demonstrates how multi-omics approaches can decipher complex metabolic interactions, enhancing our understanding of plant metabolism.
Dr. Ling Li, one of the study’s lead researchers, stated, “This research unravels the complex metabolic network within Artemisia annua, spotlighting the vital role of glandular secretory trichomes. Identifying specific genes responsible for artemisinin deficiency in the tdd1 mutant lays a crucial foundation for future studies aimed at boosting antimalarial drug production.”
The insights from this study hold significant potential for enhancing antimalarial drug production by targeting specific metabolic pathways in Artemisia annua. Deciphering the genetic and metabolic framework of GSTs can lead to refined cultivation techniques and genetic modifications that enhance artemisinin yields. Additionally, this research opens avenues for exploring other valuable secondary metabolites in A. annua, potentially leading to the discovery of new medicinal compounds beyond artemisinin.
###
References
DOI
Original Source URL
https://doi.org/10.1093/hr/uhae174
Funding information
This work was supported by the Natural Science Foundation of Sichuan Province (2024NSFSC1831), the Bill & Melinda Gates Foundation (INV-027291), the National Key R&D Program of China (2018YFA0900600), and the Xinglin Scholar Research Premotion Project of Chengdu University of Traditional Chinese Medicine (XJ2023000302).
About Horticulture Research
Horticulture Research is an open access journal of Nanjing Agricultural University and ranked number one in the Horticulture category of the Journal Citation Reports ™ from Clarivate, 2022. The journal is committed to publishing original research articles, reviews, perspectives, comments, correspondence articles and letters to the editor related to all major horticultural plants and disciplines, including biotechnology, breeding, cellular and molecular biology, evolution, genetics, inter-species interactions, physiology, and the origination and domestication of crops.
